Chan, T. A., Yarchoan, M., Jaffee, E., Swanton, C., Quezada, S. A., Stenzinger, A., & Peters, S. (2019). Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic. Annals of oncology, 30(1), . https://doi.org/10.1093/annonc/mdy495
Chicago-Zitierstil (17. Ausg.)Chan, Timothy A., M. Yarchoan, E. Jaffee, C. Swanton, S. A. Quezada, Albrecht Stenzinger, und S. Peters. "Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic." Annals of Oncology 30, no. 1 (2019). https://doi.org/10.1093/annonc/mdy495.
MLA-Zitierstil (9. Ausg.)Chan, Timothy A., et al. "Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic." Annals of Oncology, vol. 30, no. 1, 2019, https://doi.org/10.1093/annonc/mdy495.